News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Oculis Holding AG
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
March 03, 2026
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Appoints Katie Kazem as Chief Legal Officer
February 17, 2026
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
January 08, 2026
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
January 06, 2026
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Reports Q3 2025 Financial Results and Provides Company Update
November 10, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Participate in Upcoming November Investor Conferences
November 05, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development
October 30, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025
October 14, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
October 06, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
September 22, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
September 04, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
September 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Participate in Upcoming September Investor Conferences
August 28, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
August 25, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Reports Q2 2025 Financial Results and Provides Company Update
August 21, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
August 12, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Upsized Loan Facility to Access up to CHF 100 million
August 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Publishes Results of 2025 Annual General Meeting
June 05, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Participate in Upcoming June Investor Conferences
June 03, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Publishes Invitation to the Annual General Meeting
May 09, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Reports Q1 2025 Financial Results and Provides Company Update
May 08, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Present at Upcoming May Investor Conferences
May 07, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences
May 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award
April 17, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
April 15, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond
April 01, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy
January 06, 2025
From
Oculis Holding AG
Via
GlobeNewswire
Tickers
OCS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.